A Chinese man with chronic recalcitrant hidradenitis suppurativa successfully treated with infliximab
以因福利美成功治癒華人男性患者慢性頑固性化膿性汗腺炎

CK Kwan 關志強 and LY Chong 莊禮賢

A 31-year-old Chinese male suffered from recalcitrant hidradenitis suppurativa for seven years causing disfiguring scars over the face and intertriginous areas, particularly the axillae and groins. Multiple medical treatments and surgical operation were tried but in vain. Infliximab infusion led to significant improvement. To our best knowledge, this is the first Chinese patient with hidradenitis suppurativa treated with infliximab in Hong Kong.

31歲中國男性患有化膿性汗腺炎七年， 面上、腋窩、腹股溝都長滿了疤痕。多種藥物治療和外科手術都沒有成效。當轉用生物製劑因福利美（infliximab）後，結果病情有明顯的改善。就我們所知，這是香港首名化膿性汗腺炎病人使用生物製劑因福利美（infliximab）。

Keywords : Ankylosing spondylitis, hidradenitis suppurativa, infliximab

關鍵詞：強直性脊椎炎，化膿性汗腺炎， 因福利美